Lymphangiomahttps://en.wikipedia.org/wiki/Lymphangioma
Lymphangioma Malformationes systematis lymphatici propriae sunt laesiones tenues muratae anorum. Hae malformationes quacumque aetate fieri possunt et partem corporis involvere, sed 90 % in pueris sub duobus annis occurrunt, praesertim caput et collum. Lymphangiomae plerumque ante partum, per ultrasonographiam foetus, praecognitae sunt. Lymphangioma quaesitum provenire potest ex trauma, inflammatione vel obstructione lymphatica. Cum nullam occasionem maligni habeant, lymphangiomae solent tantum propter rationes benignas medicamine tractari.

☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
References Recent Progress in Lymphangioma 34976885 
NIH
Lymphangioma notum est etiam ut malformatio lymphatica (LM). Perturbatio vasculorum est praesens a nativitate. Incrementum anormale textus lymphatici ante et post partum notatur. Lymphangioma afficit circiter 1 in 2000‑4000 hominum, nulla significativa differentia inter genera vel gentes. Pleraque (80‑90 %) praecogniti sunt ante duos annos. Symptoma varii sunt, a tumore locali ad abnormitates in canalibus lymphaticis latis, interdum ad tumorem gravem, quod elephantiasis notatur. Exempli gratia, lymphangioma in collo et facie potest producere tumor faciei; in gravibus casibus deformitatem inducere. Cum linguam afficit, potest ducere ad excrescentias maxillares et dentes malpositos. In ore et collo, potest causare difficultates respirandi et casus vitae minaces. In oculis, potest provocare damnum visionis, motus oculi limitatum, palpebras demissas, et edema ocularis. Involvementum membrorum potest producere tumor et incrementum anormale textuum et ossium. Tumor tardius crescit, sed infectiones, mutationes hormonales, vel trauma possunt accelerare incrementum, creando pericula vitae minacia, quae curationem urgentem requirunt.
Lymphangioma (lymphatic malformation, LM), a congenital vascular disease, is a low-flow vascular abnormality in lymphatic diseases that is characterized by excessive growth of lymphatic tissue during prenatal and postpartum development. The incidence rate of LM is ~1:2000–4000, with no variation between genders and races. Most patients (80–90%) are diagnosed before the age of two. The clinical manifestations of lymphangioma are quite different among patients, varying from local swelling leading to superficial mass to a large area of diffuse infiltrating lymphatic channel abnormalities resulting in elephantiasis. Cervicofacial LM can cause facial elephantiasis, and in some severe cases, it can lead to serious disfigurement of the face. Tongue LM can lead to mandibular overgrowth and occlusal asymmetry, and oral and cervical LM can cause obstructive acute respiratory distress and life-threatening situations. Orbital LM may lead to decreased vision, decreased extraocular muscle movement, ptosis and exophthalmos. LM of the extremities can trigger swelling or gigantism, accompanied by overgrowth of soft tissue and bones. LM usually grows slowly and steadily, but under certain conditions, such as infection, hormonal changes or trauma, it can grow explosively and become a life-threatening disease requiring immediate treatment.
 Lymphangioma: Is intralesional bleomycin sclerotherapy effective? 22279495 
NIH
In hoc studio retrospectivo recensuimus viginti quattuor patientes qui lymphangioma habebant et injectiones solutionis bleomycin a Ianuario MCMXCIX ad Decembrem MMIV tractavimus. Pleraque lesionum (63 %) perfectam remissionem obtinuerunt, 21 % bonam responsionem acceperunt, et 16 % non bene responderunt. Duo aegeribus gravibus tumor, alii duo abscessibus, ubi injectiones acceperunt. Feliciter alias graves difficultates vel effectus laterales non observavimus.
This is a retrospective study of 24 children diagnosed with lymphangioma and treated with intralesional injection of bleomycin aqueous solution from January 1999 to December 2004. Complete resolution was seen in 63% (15/24) of lesions, 21% (5/24) had good response and 16% (4/24) had poor response. The tumour recurred in 2 patients. Two other patients had abscess formation at the site of injection. No other serious complications or side effects were observed.
 Surgical Resection of Acquired Vulvar Lymphangioma Circumscriptum - Case reports 24665431 
NIH
Genera lymphangiomatum principalia haec sunt: lymphangioma circumscriptum, cavernous lymphangioma, cystic hygroma, lymphangioendothelioma. Haec circa 26 % tuberculorum benignorum in pueris constituunt, sed in adultis minus communia sunt. Lymphangioma circumscriptum, typus frequentissimus, ductus lymphatici per cutem prominentes ostendit, vesiculas repletas liquido, similes ranae parientis, formans cum tumore texti. Plerumque in regionibus apparet cum retibus lymphaticis abundanter, ut membra, truncus et alas. Femina LXXI annorum ad nostram clinicam pervicit cum tumore cruris persistente, rosea eruptione in genitalibus, pruritu et fluido lymphatico stillante. Omnes labella chirurgice removimus per labiectomiam bilateralem magnam, quae in fascia Colles' sita est, servantes clitoridem et fourchette.
The predominant types of lymphangioma are lymphangioma circumscriptum (LC), cavernous lymphangioma, cystic hygroma, and lymphangioendothelioma. These entities account for approximately 26% of benign vascular tumors in children but are rarer in adults. LC is the most common form of cutaneous lymphangioma and is characterized by superficial lymphatic ducts protruding through the epidermis. This condition results in clusters of clear fluid-filled vesicles resembling frog spawn and associated tissue edema. It is usually found on the proximal extremity, trunk, and axilla, which has an abundant lymphatic system. A 71-year-old female presented to our outpatient clinic with persistent edema of both lower limbs, clusters of pink labial papules, pruritus, and watery lymph oozing. We removed all the papules by performing bilateral major labiectomy down to the level of Colles' fascia, sparing the clitoris and fourchette.